{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode'])) @else
@endif

Survey Questionnaire Form

Assessment of dermatophytosis epidemiology, management practices and attitudes- A pan India Survey of Dermatologists in India
Doctor’s details

{{--

--}}

Questionnaire

  1. What are the total number of patients visited in your clinic in last 10 days for skin consultation *
  2. What % of total patients visited in last 10 days were infected by dermatophytosis *
  3. Of total tinea patients you see in your clinic, what % is male population *
  4. What are the most prevalent type of Tinea in your patients. Kindly mention % of each type of dermatophytosis considering patients with dermatophytosis seen by you as 100% *
  5. Tinea corporis
    %
    Tinea cruris
    %
    Tinea captitis
    %
    Tinea pedis
    %
    Tinea unguium
    %
    Tinea faciei
    %
    Tinea manuum
    %
  6. What % of your dermatophytosis patients are treatment naïve *
  7. What % of your patients do you manage by only topical formulations? *
  8. In which all conditions do you use only topical formulations in your patients? *
  9. What is the 1st, 2nd and 3rd line treatment for tinea infection among topical application *
  10. 1st line treatment 2nd line treatment 3rd line treatment
    Tinea corporis

    Tinea cruris

    Tinea pedis

  11. What is the 1st, 2nd and 3rd line treatment for tinea infection among systemic administration *
  12. 1st line treatment 2nd line treatment 3rd line treatment
    Tinea corporis

    Tinea cruris

    Tinea pedis

  13. What is average duration of treatment in tinea infection *
  14. What is % of patients in which Luliconazole is prescribed *
  15. What is the most common systemic and topical antifungal combination that you prefer in your patients? *
  16. What is % of patients in which Anti-fungal soaps are prescribed *
  17. In what % of patients relapse is observed *
  18. What are the current challenges you are facing during treatment of Tinea *